These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21447274)

  • 1. [Polycystic ovary syndrome in type 1 diabetes].
    Lebkowska A; Kowalska I
    Pediatr Endocrinol Diabetes Metab; 2010; 16(4):306-9. PubMed ID: 21447274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A syndrome of their own: PCOS and its links to diabetes in women.
    Gebel E
    Diabetes Forecast; 2012 Sep; 65(9):32, 34. PubMed ID: 22970510
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of polycystic ovary syndrome in women with type 2 diabetes in Kerman, Iran.
    Mirzaei F; Kazemi N
    Metab Syndr Relat Disord; 2008 Sep; 6(3):215-7. PubMed ID: 18710333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes.
    Amini M; Horri N; Farmani M; Haghighi S; Sattari G; Pornaghshband Z; Aminorroaya A
    Gynecol Endocrinol; 2008 Aug; 24(8):423-7. PubMed ID: 18850378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973-1991.
    Mumm H; Kamper-Jørgensen M; Nybo Andersen AM; Glintborg D; Andersen M
    Fertil Steril; 2013 Mar; 99(3):777-82. PubMed ID: 23200688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic Ovary Syndrome (PCOS) in Juvenile and Adult Type 1 Diabetes in a German/Austrian Cohort.
    Reinauer C; Bollow E; Fröhlich-Reiterer E; Laubner K; Bergis D; Schöfl C; Kempe HP; Hummel M; Hennes P; Gollisch K; Haberland H; Datz N; Meissner T; Holl RW
    Exp Clin Endocrinol Diabetes; 2017 Nov; 125(10):661-668. PubMed ID: 28926868
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia.
    Hahn S; Tan S; Elsenbruch S; Quadbeck B; Herrmann BL; Mann K; Janssen OE
    Horm Metab Res; 2005 Jul; 37(7):438-44. PubMed ID: 16034717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS.
    Sawathiparnich P; Weerakulwattana L; Santiprabhob J; Likitmaskul S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S33-7. PubMed ID: 16856423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polycystic ovarian syndrome and diabetes].
    Carlsen SM; Salvesen KA; Vanky E; Fougner KJ
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2619-21. PubMed ID: 16215603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in the polycystic ovary syndrome.
    Dunaif A; Thomas A
    Annu Rev Med; 2001; 52():401-19. PubMed ID: 11160786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
    Shi Y; Gao X; Sun X; Zhang P; Chen Z
    Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.
    Checa MA; Requena A; Salvador C; Tur R; Callejo J; Espinós JJ; Fábregues F; Herrero J;
    Hum Reprod Update; 2005; 11(4):375-90. PubMed ID: 15878899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Economou F; Palimeri S; Christakou C
    Ann N Y Acad Sci; 2010 Sep; 1205():192-8. PubMed ID: 20840272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome.
    Lazaridou S; Dinas K; Tziomalos K
    Hormones (Athens); 2017 Oct; 16(4):373-380. PubMed ID: 29518757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.